Three patients with a muscle-wasting disease died from liver failure after taking the therapy, Ele­vidys, or a similar ...

Dive Brief: The Food and Drug Administration is reviewing Alvotech’s newest application for its Humira biosimilar, setting a Feb. 24 deadline to decide on approval, the company said Wednesday. The ...

The comeback story of belantamab mafodotin (Blenrep) hit a roadblock Thursday as the FDA's Oncologic Drugs Advisory Committee ...

Under [the plaintiffs'] reading, virtually all pharmaceutical product-support services would qualify as a kickback,” U.S.